×
Back to Agenda
Session 4A: (Parallel Session) Supporting Innovation - Pharm & Bio
Session Chair(s)
Mei Ding
JAPAC Regional Lead, Policy & Intelligence, Abbvie Pte. Ltd., Singapore
Speaker(s)
Marta Parmar
Assoc. Director- Regulatory Affairs CMC GEM AsiaPac , Biogen (Singapore) Pte Ltd, Singapore
Support to Quality Development in Early Access Approaches
Steve Davidsen
Vice President, Abbvie, Singapore
Next Generation Antibody Drug Conjugates
Richard Hopkins
Research Director, R&D, Tessa Therapeutics Pte Ltd, Singapore
Virus Specific T Cells as Platform for Solid Tumor Immunotherapy
May Wei
VP, Regulatory Affairs , Moleac Pte Ltd, Singapore
Drive Botanical Drugs to Work-class Development
Yun-Long Tseng
Vice President, Taiwan liposomal Companies, Taiwan
Liposome for targeting and sustained release in clinical use
Have an account?